OraSure Technologies Inc (NASDAQ:OSUR)

16.08
Delayed Data
As of 4:00pm ET
 +0.05 / +0.31%
Today’s Change
12.86
Today|||52-Week Range
23.01
-14.74%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$966.6M

Company Description

OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices. The DNAG segment manufactures and sells specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.

Contact Information

OraSure Technologies, Inc.
220 East 1st Street
Bethlehem Pennsylvania 18015
P:(610) 882-1820
Investor Relations:
161088218201476

Employees

Shareholders

Individual stakeholders9.02%
Other institutional48.45%
Mutual fund holders47.04%

Top Executives

Stephen S. TangChairman, President & Chief Executive Officer
Ronald H. SpairDirector, Chief Operating & Financial Officer
Michael ReedChief Science Officer, SVP-Research & Development
Jack E. JerrettSecretary, Senior Vice President & General Counsel
Kathleen G. WeberSenior Vice President & GM-Consumer Products